MedPath

Effect of alpha-lipoic acid supplement in rheumatoid arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis.
Rheumatoid arthritis, unspecified
Registration Number
IRCT201205263140N5
Lead Sponsor
Research Vice-chancellor of Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

female rheumatoid arthritis patients who have ACR criteria 1987 for RA; Age range of 20 to 50 years; disease activity score-28< 5.1; not changing the treatment protocol since 2 months before the study, not receiving antioxidant or anti inflammatory supplements since 1 month before the study; desire to attend in study and signing the informed consent form. Exclusion criteria: pregnancy; lactation; post menopause; receiving hormone replacement therapy; receiving oral contraceptive pill; smoking or being a passive smoker; presence of cancer; diabetes mellitus; hormonal dysfunctions; under nutrition; severe obesity (BMI>40), uncontrolled hypertension; renal failure and hepatic diseases; digestive disorders; other autoimmune and/or inflammatory disease; changing treatment protocol and lifestyle during the study; receiving antioxidant or anti-inflammatory supplements during the study; acceptance rate<75% and unwillingness to continue the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath